Amedisys Inc (AMED) Social Stream



Amedisys Inc (AMED): $156.79

2.60 (+1.69%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Amedisys Inc (AMED) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering AMED.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
13 $265 $195 $240.92 $150.58 59.99%

The Trend in the Analyst Price Target


Over the past 16 months, AMED's average price target has gone up $28.46.

Over the past 16 months, AMED's average upside potential has been 21.78%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 13 265 195 240.92 167.67 43.69%
2021-09-19 13 265 195 240.92 171.13 40.78%
2021-09-18 13 265 195 240.92 171.13 40.78%
2021-09-11 12 265 220 244.75 180.25 35.78%
2021-09-04 12 265 220 244.75 183.17 33.62%
2021-08-28 12 265 220 244.75 177.56 37.84%
2021-08-14 12 320 220 251.17 180.62 39.06%
2021-08-07 12 340 220 288.25 191.34 50.65%
2021-08-05 12 350 310 330.25 200.13 65.02%
2021-08-01 12 350 310 330.25 260.62 26.72%
2021-07-24 12 350 310 330.25 264.00 25.09%
2021-07-17 12 350 310 330.25 258.44 27.79%
2021-07-10 12 350 310 330.25 269.93 22.35%
2021-07-03 12 350 310 330.25 264.66 24.78%
2021-06-26 12 350 310 331.92 249.72 32.92%
2021-06-13 12 350 310 331.92 252.93 31.23%
2021-06-05 12 350 310 331.92 255.61 29.85%
2021-05-22 12 350 310 331.92 258.96 28.17%
2021-05-15 12 350 310 331.92 256.97 29.17%
2021-05-08 12 350 310 331.92 260.13 27.6%
2021-04-25 12 340 300 327.33 284.57 15.03%
2021-04-17 12 340 300 327.33 282.96 15.68%
2021-04-10 12 340 300 327.33 283.09 15.63%
2021-04-03 12 340 300 329.00 269.46 22.1%
2021-03-20 13 340 261 323.77 269.00 20.36%
2021-03-13 13 340 261 323.77 266.30 21.58%
2021-03-06 13 340 261 323.77 241.25 34.21%
2021-02-27 13 340 261 323.77 253.64 27.65%
2021-02-20 13 340 261 316.69 292.48 8.28%
2021-02-13 13 340 261 316.69 308.82 2.55%
2021-02-06 14 340 261 313.00 298.83 4.74%
2021-01-30 14 340 261 313.00 287.31 8.94%
2021-01-23 14 340 261 309.43 313.54 -1.31%
2021-01-16 14 340 261 309.43 293.89 5.29%
2021-01-09 14 340 261 302.14 307.07 -1.61%
2021-01-02 14 310 261 283.64 293.33 -3.3%
2020-12-26 14 310 261 283.64 292.35 -2.98%
2020-12-19 14 300 261 280.79 289.80 -3.11%
2020-12-09 14 300 261 280.79 262.40 7.01%
2020-12-07 14 300 261 280.79 255.74 9.8%
2020-11-15 14 300 261 280.79 243.43 15.35%
2020-11-02 14 300 261 280.79 254.38 10.38%
2020-10-29 14 300 250 279.43 250.87 11.38%
2020-09-17 14 290 245 258.29 NA NA%
2020-09-09 14 290 245 257.57 NA NA%
2020-09-01 14 290 235 256.86 NA NA%
2020-08-19 14 290 235 255.43 NA NA%
2020-07-31 13 270 235 252.23 NA NA%
2020-07-22 13 260 190 218.00 NA NA%
2020-07-16 13 260 190 218.00 NA NA%
2020-07-11 13 260 190 214.38 NA NA%
2020-07-01 13 240 190 212.85 NA NA%
2020-06-17 13 240 190 212.85 NA NA%
2020-06-07 13 240 190 212.46 NA NA%

AMED Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.62 3 7 5 0 0 16

The Trend in the Broker Recommendations


Over the past 30 days, AMED's average broker recommendation rating worsened by 0.18.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The average analyst price target of AMED is higher than 95.12% of all US stocks.
  • AMED has a higher number of analysts covering the stock than 89.96% of Healthcare stocks.
  • The upside potential (average analyst target price relative to current price) of AMED is greater than 84.64% of stocks in the mid market cap category.
  • Amedisys Inc's variance in analysts' estimates is lower than 60.33% of Healthcare stocks.

Stocks similar to Amedisys Inc in the Healthcare industry regarding analyst recommendations and price targets are LHCG, DGX and THC.

What is the outlook for AMED? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7619 seconds.